Showing 1 to 12 of 123 results
Turkey's Diabetes Prevalence: A 67% Surge in Two Decades
Turkey's diabetes prevalence has increased by 67% in 20 years, reaching 16.6% in 2022, nearly double the EU average, prompting calls for improved healthcare policies and public health initiatives.
Turkey's Diabetes Prevalence: A 67% Surge in Two Decades
Turkey's diabetes prevalence has increased by 67% in 20 years, reaching 16.6% in 2022, nearly double the EU average, prompting calls for improved healthcare policies and public health initiatives.
Progress
28% Bias Score
High Dropout Rate Among Weight Loss Drug Users
A new analysis reveals that 52 percent of over 77,000 people using anti-obesity drugs in Denmark stopped within a year, raising concerns about long-term adherence and highlighting socioeconomic disparities in access.
High Dropout Rate Among Weight Loss Drug Users
A new analysis reveals that 52 percent of over 77,000 people using anti-obesity drugs in Denmark stopped within a year, raising concerns about long-term adherence and highlighting socioeconomic disparities in access.
Progress
20% Bias Score
Canada to Expand Pharmacare Coverage
Canadian Prime Minister Mark Carney announced that the federal government will finalize agreements with remaining provinces and territories to expand public coverage for diabetes medications, supplies, and contraceptives, addressing previous inequities in access.
Canada to Expand Pharmacare Coverage
Canadian Prime Minister Mark Carney announced that the federal government will finalize agreements with remaining provinces and territories to expand public coverage for diabetes medications, supplies, and contraceptives, addressing previous inequities in access.
Progress
24% Bias Score
Canada's Pharmacare Rollout Faces Uncertainty as Talks Stall
Following a federal election, the implementation of Canada's Pharmacare Act is facing uncertainty as the federal government has yet to resume talks with several provinces and territories regarding agreements for free access to essential medications and supplies.
Canada's Pharmacare Rollout Faces Uncertainty as Talks Stall
Following a federal election, the implementation of Canada's Pharmacare Act is facing uncertainty as the federal government has yet to resume talks with several provinces and territories regarding agreements for free access to essential medications and supplies.
Progress
28% Bias Score
High Percentage of Undiagnosed Diabetes Globally
A new Lancet study reveals that 44% of people aged 15 and older with diabetes are undiagnosed, with younger adults less likely to be diagnosed than older adults, highlighting the need for increased screening and awareness.
High Percentage of Undiagnosed Diabetes Globally
A new Lancet study reveals that 44% of people aged 15 and older with diabetes are undiagnosed, with younger adults less likely to be diagnosed than older adults, highlighting the need for increased screening and awareness.
Progress
16% Bias Score
55,000 Diabetes Patients Need Retesting Due to Machine Errors
In England, faulty diabetes testing machines have resulted in at least 55,000 patients requiring retests, with some wrongly diagnosed and medicated; the issue stems from 16 hospital trusts using Trinity Biotech machines, first flagged in April 2024.
55,000 Diabetes Patients Need Retesting Due to Machine Errors
In England, faulty diabetes testing machines have resulted in at least 55,000 patients requiring retests, with some wrongly diagnosed and medicated; the issue stems from 16 hospital trusts using Trinity Biotech machines, first flagged in April 2024.
Progress
16% Bias Score
Novo Nordisk Partners with Pocketpills for Ozempic and Wegovy Home Delivery
Novo Nordisk Canada has partnered with Pocketpills, a Canadian online pharmacy, to offer home delivery of its diabetes and obesity drugs, Ozempic and Wegovy, streamlining the ordering process and providing discounts.
Novo Nordisk Partners with Pocketpills for Ozempic and Wegovy Home Delivery
Novo Nordisk Canada has partnered with Pocketpills, a Canadian online pharmacy, to offer home delivery of its diabetes and obesity drugs, Ozempic and Wegovy, streamlining the ordering process and providing discounts.
Progress
16% Bias Score
New Barbie Doll Features Type 1 Diabetes
Mattel released a new Barbie doll with type 1 diabetes, including accessories like a continuous glucose monitor and insulin pump, in collaboration with Breakthrough T1D to increase representation and understanding of the condition.
New Barbie Doll Features Type 1 Diabetes
Mattel released a new Barbie doll with type 1 diabetes, including accessories like a continuous glucose monitor and insulin pump, in collaboration with Breakthrough T1D to increase representation and understanding of the condition.
Progress
20% Bias Score
High Percentage of Undiagnosed Diabetes Cases Globally
A new Lancet study reveals that 44% of people with diabetes globally are undiagnosed, with younger adults less likely to be aware of their condition than older adults, highlighting the need for improved screening and treatment.
High Percentage of Undiagnosed Diabetes Cases Globally
A new Lancet study reveals that 44% of people with diabetes globally are undiagnosed, with younger adults less likely to be aware of their condition than older adults, highlighting the need for improved screening and treatment.
Progress
16% Bias Score
44% of People with Diabetes Are Undiagnosed, Study Finds
A new Lancet study reveals that 44% of people aged 15 and older with diabetes globally are undiagnosed, highlighting significant variations across countries and age groups, with younger adults less likely to be aware of their condition.
44% of People with Diabetes Are Undiagnosed, Study Finds
A new Lancet study reveals that 44% of people aged 15 and older with diabetes globally are undiagnosed, highlighting significant variations across countries and age groups, with younger adults less likely to be aware of their condition.
Progress
16% Bias Score
Artificial Sweeteners Linked to Accelerated Cognitive Decline in Study
A Brazilian study of nearly 13,000 adults found that higher artificial sweetener consumption correlated with a 62% faster decline in cognitive abilities, equivalent to 1.6 years of aging, particularly among those with diabetes.
Artificial Sweeteners Linked to Accelerated Cognitive Decline in Study
A Brazilian study of nearly 13,000 adults found that higher artificial sweetener consumption correlated with a 62% faster decline in cognitive abilities, equivalent to 1.6 years of aging, particularly among those with diabetes.
Progress
16% Bias Score
Artificial Sweeteners Linked to Accelerated Cognitive Decline in Middle-Aged Adults
A study of almost 13,000 Brazilian adults found a correlation between high artificial sweetener consumption and a 62% faster decline in cognitive skills, particularly in those with diabetes, but not in participants over 60.
Artificial Sweeteners Linked to Accelerated Cognitive Decline in Middle-Aged Adults
A study of almost 13,000 Brazilian adults found a correlation between high artificial sweetener consumption and a 62% faster decline in cognitive skills, particularly in those with diabetes, but not in participants over 60.
Progress
16% Bias Score
Showing 1 to 12 of 123 results